The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Urology diagnostics maker MedicaMetrix Inc. landed a $66,950 grant under the Medical Device Development Center’s "fast-lane" program to continue the development of its ProstaGlove for low cost detection of prostate cancer.
The grant was supported by the Massachusetts Technology Collaborative’s John Adams Innovation Institute.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
Zimmer Holdings (NYSE:ZMH) is suing another law firm over an ad campaign that allegedly makes false and defamatory statements about its NexGen knee implant.
The lawsuit accuses Ohio law office Elk & Elk Co. of running Internet and television spots aimed at Zimmer customers which stated that the NexGen device "has a high failure rate, causes pain, has resulted in the recall of the NexGen CR-Flex product and is otherwise defective," according to court documents.
Kensey Nash Corp. (NSDQ:KNSY) landed a small business innovation research grant from the National Institutes of Health to investigate the use of surgical mesh for tendon repair procedures.
The two-year, $1.9 million grant will allow the Exton, Pa.-based regenerative medicine developer to investigate the ability of its bioadhesive mesh to improve standard sutured tendon repair.
Zimmer Holdings (NYSE:ZMH) shares are down this morning in early trading after the orthopedics giant lowered its sales and earnings guidance for 2011 – despite beating analysts’ expectations with its third-quarter earnings.
Warsaw, Ind.-based Zimmer said third-quarter profits were $192 million, or $1.01 per share, on sales of $1.03 billion for the three months ended Sept. 30, up 5.2 percent and 6.9 percent, respectively, compared with the same period last year.
Zimmer Holdings (NYSE:ZMH) shares are down this morning in early trading after the orthopedics giant lowered its sales and earnings guidance for 2011 – despite beating analysts’ expectations with its third-quarter earnings.
Warsaw, Ind.-based Zimmer said third-quarter profits were $192 million, or $1.01 per share, on sales of $1.03 billion for the three months ended Sept. 30, up 5.2 percent and 6.9 percent, respectively, compared with the same period last year.
MASSDEVICE ON CALL — The top artificial hip and knee makers cut spending on consultants after a federal case charged them with providing illegal kickbacks.
AtriCure Inc. (NSDQ:ATRC) could be poised for a buyout over the next year to 18 months, according to Canaccord Genuity analyst Jason Mills.
Expectations of softer markets for hip and knee implants prompted analysts at Leerink Swann to lower their sales and earnings expectations for Stryker Corp. (NYSE:SYK) and Zimmer Holdings (NYSE:ZMH).
The researchers said they adjusted their takes on companies’ the top and bottom lines "primarily to reflect more conservative hip/knee growth assumptions."
